In 2023, the import of insulin in dosage forms to Japan stood at 1.375 million kilograms. The forecasted values for the years 2024 to 2028 show a consistent yearly increase: 2024 by 1.27%, 2025 by 1.32%, 2026 by 1.28%, 2027 by 1.24%, and 2028 by 1.19%. The Compound Annual Growth Rate (CAGR) over the next five years is approximately 1.26%, indicating a steady upward trend.
Future trends to watch for:
• Advancements in diabetes treatment technologies.
• Shifts in consumer demand due to aging population.
• Impact of domestic insulin production developments.
• Policy changes affecting pharmaceutical imports.
